Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/26/2012WO2012099258A1 Therapeutic agent for alopecia
07/26/2012WO2012099238A1 Composition for promoting lipolysis
07/26/2012WO2012099224A1 Extract of aquatic animal cartilage
07/26/2012WO2012098546A2 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
07/26/2012WO2012098537A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
07/26/2012WO2012098462A1 Combination of acylated glucagon analogues with insulin analogues
07/26/2012WO2012098449A1 Methods for treating disorders that involve immunoglobulin a
07/26/2012WO2012098397A1 Combination therapy for cancer
07/26/2012WO2012098203A1 Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
07/26/2012WO2012098188A1 Glp-1 particles and compositions
07/26/2012WO2012098187A1 Glp-1 compositions
07/26/2012WO2012098009A1 Chimeric polypeptide comprising a membrane protein and an insulin precursor
07/26/2012WO2012075506A3 Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
07/26/2012WO2012069474A3 A method for reducing potential virus burden in a sample by cyanate treatment
07/26/2012WO2012068355A3 Treating aortic aneurysm by modulating toll-like receptors
07/26/2012WO2012050402A3 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same
07/26/2012WO2012042038A3 Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9
07/26/2012WO2012037485A8 Methods of inhibiting alphavirus replication and treating alphavirus infection
07/26/2012WO2012021891A4 Compositions, kits and methods for treatment of complement-related disorders
07/26/2012US20120192294 Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease
07/26/2012US20120190909 Uses of il-12 in hematopoiesis
07/26/2012US20120190832 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
07/26/2012US20120190821 Recombinant soluble fc receptors
07/26/2012US20120190727 Method and means for treatment of osteoarthritis
07/26/2012US20120190717 Methods and compositions for increasing the anaerobic working capacity in tissues
07/26/2012US20120190630 Amino acid-based compounds, their methods of use, and methods of screening
07/26/2012US20120190629 Light-receiving channel rhodopsin having improved expression efficiency
07/26/2012US20120190628 Genes and polypeptides relating to human colon cancers
07/26/2012US20120190627 Cosmetic use of lacritin-type polypeptides
07/26/2012US20120190626 Amyloid beta fibrillogenesis-inhibiting peptide
07/26/2012US20120190625 Novel peptide and use thereof
07/26/2012US20120190624 Psi-epsilon rack peptide composition and method for protection against tissue damage due to ischemia
07/26/2012US20120190623 Inactivation Resistant Factor VIII
07/26/2012US20120190622 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
07/26/2012US20120190621 Corneal endothelial cell proliferation promoter
07/26/2012US20120190620 Methods to identify targets and molecules regulating purinosomes and their uses
07/26/2012US20120190619 Methods of identifying anti-inflammatory compounds
07/26/2012US20120190618 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
07/26/2012US20120190617 Niacin and/or trigonelline as a muscle stimulant
07/26/2012US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59
07/26/2012US20120190615 Methods and compositions for inducing weight loss
07/26/2012US20120190614 Hcv protease inhibitors and uses thereof
07/26/2012US20120190613 Echinocandin derivatives
07/26/2012US20120190612 Methods of treatment
07/26/2012US20120190611 Method for treatment of inflammatory disease and disorder
07/26/2012US20120190610 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
07/26/2012US20120190609 Method for producing a lipid particle, the lipid particle itself and its use
07/26/2012US20120190569 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
07/26/2012US20120190035 Detection Of Disease Related Genes
07/26/2012US20120189711 Modular Extracorporeal Systems and Methods for Treating Blood-Borne Diseases
07/26/2012US20120189709 Method of using beta-hydroxy-beta-methylbutyrate to treat a condition
07/26/2012US20120189704 Novel injectable chitosan mixtures forming hydrogels
07/26/2012US20120189703 Enzyme Delivery Systems and Methods of Preparation and Use
07/26/2012US20120189698 Pharmaceutical Dosage Forms for the Release of Active Compounds
07/26/2012US20120189691 Drug carrier and drug carrier kit for inhibiting fibrosis
07/26/2012US20120189690 Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein
07/26/2012US20120189688 Carrier component and fabrication method thereof
07/26/2012US20120189687 Compositions and Methods for Topical Application of Growth Factors and Cytokines
07/26/2012US20120189682 Inhibition of biofilm organisms
07/26/2012US20120189677 Formulations
07/26/2012US20120189673 Polypeptides and uses thereof
07/26/2012US20120189672 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
07/26/2012US20120189671 Absorbable Implants and Methods for their use in Hemostasis
07/26/2012US20120189669 Solid Forms for Tissue Repair
07/26/2012US20120189668 Hydrogel bioscaffold and coating for bone and tooth repair
07/26/2012US20120189666 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
07/26/2012US20120189659 Attenuated pestiviruses
07/26/2012US20120189647 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
07/26/2012US20120189641 Combination anti-cancer therapy
07/26/2012US20120189638 Method of treating neurodegenerative disease
07/26/2012US20120189634 Taci as an anti-tumor agent
07/26/2012US20120189631 Pharmaceutical composition for treating ischemic events
07/26/2012US20120189625 Compositions and Methods for Treating Hematological Cancers Targeting the SIRPA CD47 Interaction
07/26/2012US20120189619 Methods for treating a spinal disorder or osteoarthritis using dominant negative tissue necrosis factor
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120189613 Stim2-mediated capacitive calcium entry
07/26/2012US20120189612 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
07/26/2012US20120189610 Treatment of pain
07/26/2012US20120189609 Improvement to trabeculectomy
07/26/2012US20120189608 New endolysin obpgplys
07/26/2012US20120189607 Method of regulating fertilizing ability using cyclic adp-ribose and cd38
07/26/2012US20120189606 Antimicrobial Agents
07/26/2012US20120189605 Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof
07/26/2012US20120189604 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
07/26/2012US20120189602 Treatment and prevention of pulmonary conditions
07/26/2012US20120189597 Nutritional compositions including exogenous nucleotides
07/26/2012US20120189588 Compositions and Methods for Implantation of Processed Adipose Tissue and Processed Adipose Tissue Products
07/26/2012US20120189587 Cell sheet for tissue repair and bio-artificial tissue engineering, method of producing the same and method of using the same
07/26/2012US20120189586 Human Placental Derived Extracellular Matrix and Uses Therof
07/26/2012US20120189582 Simian adenovirus 41 and uses thereof
07/26/2012US20120189581 Use of toxoplasma and derived compositions to prevent or treat microbial infections
07/26/2012US20120189580 Anti-infective agents and uses thereof
07/26/2012US20120189579 Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
07/26/2012US20120189578 Compositions and methods for potentiating interleukin-35
07/26/2012US20120189577 Use of il-12 to increase survival following acute exposure to ionizing radiation
07/26/2012US20120189576 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
07/26/2012US20120189575 Oligodendrocyte Production from Multipotent Neural Stem Cells
07/26/2012US20120189574 Methods for hematopoietic precursor mobilization
07/26/2012US20120189573 Methods of using death receptor agonists and EGFR inhibitors
1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 3163